AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2014
Nov 20, 2014
34705_dirs_2014-11-20_3ff5e160-a08a-4dad-8f54-1c18ed6bf560.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2014-10-16
Reporting Person: PRINS RICHARD K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-07 | Common stock | G | 1000 | — | Disposed | 58000 | Direct |
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15